At Navolab, we believe that science can help ensure that every patient receives medication that is effective and safe for them.
We develop innovative diagnostic procedures in the field of autoimmune and oncological diseases.
Tovább
Billions of dollars are spent annually on drug research worldwide, and although increasingly effective drugs are available, a large number of seriously ill patients are confronted on a daily basis with the fact that the drugs prescribed to them are not effective enough and do not live up to their expectations. In many cases, the phenomenon of multidrug resistance is behind this.
TovábbA precision diagnostic device targeting inflammatory bowel disease and rheumatism – a new generation multidrug transporter kit
By directly measuring the activity of key transporter proteins—ABCB1 (P-gp), ABCC1 (MRP1), and ABCG2 (BCRP)—our diagnostic tool provides actionable insights that were previously out of reach. This enables clinicians and researchers to better understand drug resistance patterns at the individual level, leading to more informed treatment decisions and personalized therapy strategies.
With its high sensitivity, speed, and reliability, our solution represents a major step forward in addressing the impact of multidrug resistance in both clinical and research settings.
"*" indicates required fields
